Literature DB >> 12616440

Cardiovascular events before and after surgery for primary hyperparathyroidism.

Peter Vestergaard1, Charlotte L Mollerup, Vibe Gedsø Frøkjaer, Peer Christiansen, Mogens Blichert-Toft, Leif Mosekilde.   

Abstract

Cardiovascular disease [atherosclerosis and subsequent myocardial infarction (MI)] has been associated with primary hyperparathyroidism. We aimed at studying cardiovascular events before and after surgery and mortality after surgery for primary hyperparathyroidism using a historical follow-up design. A total of 674 patients who underwent surgery at three Danish centers between January 1, 1979 and December 31, 1997 were compared with 2021 age- and gender-matched controls. There was an increased incidence of acute MI up to 10 years prior to surgery [relative risk (RR) 2.5, 95% confidence interval (95% CI) 1.5-4.2] and within the first year following surgery (RR 3.6, 95% CI 1.7-7.6). The risk of MI subsequently declined to a normal level more than 1 year after surgery. Patients with MI prior to diagnosis also had a higher postoperative risk of new infarction than did patients without [odds ratio (OR) 6.0, 95% CI 1.2-30.0]. The risk of hypertension, stroke, congestive heart failure, and diabetes was increased before surgery. More than 1 year after surgery only hypertension and congestive heart failure were more frequent in patients than controls. Preoperative cardiovascular disease was associated with an increased risk of death (RR 1.8, 95% CI 1.1-2.8). Mortality following surgery was higher than in the general population between 1979 and 1990 but not between 1991 and 1997. We concluded that there was an increase in acute MI up to 10 years prior to surgery. The risk of MI decreased to a normal level after surgery, which may be important for preventing cardiovascular disease in patients with primary hyperparathyroidism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12616440     DOI: 10.1007/s00268-002-6541-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  36 in total

1.  Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism.

Authors:  D Han; S Trooskin; X Wang
Journal:  J Endocrinol Invest       Date:  2011-07-12       Impact factor: 4.256

2.  Re: The calcium scare: what would Austin Bradford Hill have thought?

Authors:  M J Bolland; A Grey; I R Reid
Journal:  Osteoporos Int       Date:  2011-09-08       Impact factor: 4.507

3.  The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism.

Authors:  Kristin Godang; Karolina Lundstam; Charlotte Mollerup; Stine Lyngvi Fougner; Ylva Pernow; Jörgen Nordenström; Thord Rosen; Svante Jansson; Mikael Hellström; Jens Bollerslev; Ansgar Heck
Journal:  Endocr Connect       Date:  2018-07-16       Impact factor: 3.335

4.  Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden.

Authors:  Helene Siilin; Ewa Lundgren; Hans Mallmin; Dan Mellström; Claes Ohlsson; Magnus Karlsson; Eric Orwoll; Osten Ljunggren
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

5.  Myocardial perfusion defects and the left ventricular ejection fraction disclosed by scintigraphy in patients with primary hyperparathyroidism.

Authors:  Christina Gerlach Ogard; Susanne Bonnichsen Søndergaard; Henrik Vestergaard; Henrik Jakobsen; Steen Levin Nielsen
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

6.  New perspectives in the management of primary hyperparathyroidism.

Authors:  John Ayuk; Mark S Cooper; Neil J L Gittoes
Journal:  Ther Adv Endocrinol Metab       Date:  2010-10       Impact factor: 3.565

7.  Molecular classification of parathyroid neoplasia by gene expression profiling.

Authors:  Carl Morrison; William Farrar; Jeff Kneile; Nita Williams; Yiwen Liu-Stratton; Alan Bakaletz; Micheala A Aldred; Charis Eng
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

8.  Comparison of different calcium supplementation methods in patients with osteoporosis.

Authors:  Sheng-Kai Ye; Xia Ren; Xiang-Xue Meng; Hai-Ying Chen
Journal:  Exp Ther Med       Date:  2019-12-18       Impact factor: 2.447

Review 9.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

Review 10.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.